Curasight AS (XSAT:CURAS) FFO per Share

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

XSAT:CURAS Curasight AS XSAT:CURAS
24 GF Score
Price kr16.75
! 2 Warning Signs
View Full Analysis

What is Curasight AS FFO per Share?

FFO per Share only applies to REITs.

XSAT:CURAS
24GF Score
Curasight AS XSAT:CURAS
FFO per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Curasight AS Business Description

Other Exchanges CUS:Germany
Address Ole Maaloes Vej 3, Kobenhavn N, Kobenhavn, DNK, DK-2200
Curasight AS is a clinical-stage radiopharmaceutical company based in Copenhagen, Denmark, developing uTREAT, a first-in-class uPAR-targeted radioligand therapy (RLT) platform designed to treat aggressive solid tumors. The Company is focused on advancing its diagnostic and therapeutic platforms through key clinical milestones.
24GF Score

Get the complete analysis for XSAT:CURAS

FFO per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr16.75
Price